Skip to content

Peptide Sequence Designer

Design peptide sequences with activity-specific motifs, charge calculation, hydrophobicity prediction, and solubility estimation. Based on known structure-activity relationships for antimicrobial, antioxidant, hormone, enzyme inhibitor, and neuropeptide classes.

Sequence Designer

to
to

Activity Class Guidelines

Antimicrobial Peptides (AMPs)

  • Net charge: +2 to +9 (lysine/arginine-rich)
  • Hydrophobic moment: 0.4–0.6
  • Amphipathic α-helix or β-sheet
  • Length: 10–30 amino acids
  • Avoid Met, Asn at protease sites
  • Examples: magainin, defensin, LL-37

Antioxidant Peptides

  • Aromatic residues (Trp, Tyr, Phe) for electron donation
  • Hydrophobic residues for lipid peroxidation inhibition
  • His for metal chelation
  • Cys for direct radical scavenging
  • Length: 5–20 amino acids
  • Examples: glutathione, kephirin, lunasin

Hormone Analogs

  • Receptor-binding pharmacophore (HFwR for melanocortin)
  • D-amino acid substitution at protease sites
  • Fatty acylation for albumin binding
  • PEGylation for extended half-life
  • Length: 5–44 amino acids (varies by hormone)
  • Examples: semaglutide, bremelanotide, oxytocin

Enzyme Inhibitors

  • Cleavage site mimicry (transition state analog)
  • D-amino acids at P1 position
  • N-methyl amide bonds at cleavage site
  • Macrocycle for protease resistance
  • Length: 4–12 amino acids
  • Examples: BPTI, aprotinin, omapatrelat

Charge and Hydrophobicity Reference

Amino Acid Charge Hydropathy Classification
Lys (K) +1 -3.9 Positive, hydrophilic
Arg (R) +1 -4.5 Positive, hydrophilic
Asp (D) -1 -3.5 Negative, hydrophilic
Glu (E) -1 -3.5 Negative, hydrophilic
His (H) +0.5 (pH 6) -3.2 Positive (histidine), polar
Leu (L) 0 3.8 Hydrophobic
Ile (I) 0 4.5 Hydrophobic
Val (V) 0 4.2 Hydrophobic
Trp (W) 0 -0.9 Aromatic, hydrophobic
Tyr (Y) 0 -1.3 Aromatic, polar
Cys (C) 0 2.5 Polar, reactive
Gly (G) 0 -0.4 Small, flexible

Frequently Asked Questions

How accurate are the generated sequences?

Generated sequences are based on known structure-activity relationships from published literature. They provide starting points for design but require experimental validation. Actual activity depends on additional factors including secondary structure, solubility, and target cell specificity.

Can I use these sequences directly in experiments?

Generated sequences should be treated as design suggestions. Before synthesis, verify that the sequence is novel (blast search), has no predicted toxicity, and meets solubility requirements. Experimental validation through minimum inhibitory concentration (MIC) assays, cell-based assays, or receptor binding studies is essential.

How is solubility estimated?

Solubility is estimated using the GRAVY (Grand Average of Hydropathy) index. GRAVY values below -0.4 indicate high solubility, -0.4 to 0 indicate moderate solubility, and above 0 indicate low solubility. Charge density and net charge also contribute to solubility predictions.

Related Resources